Chemical Conversations: Comparing Psychedelic Compounds in Therapy
Business Trip by PsyMed Ventures, a podcast exploring the future of mental health & wellness
Welcome back to Business Trip by PsyMed Ventures, a podcast exploring the future of mental health & wellness! 🍄
Matias hosted a panel at The Battery SF with renowned psychedelics experts, Allison Feduccia, Matt Baggott, and Nolan Williams.
Allison Feduccia is an educator and advocate for the responsible use of psychedelic medicines. Allison co-founded Psychedelic Support and Project New Day.
Matt Baggott is a neuroscientist who has been studying MDMA for 30 years. In 2019, he co-founded Tactogen, a company making new drugs inspired by MDMA, with the potential to be administered in an at-home setting.
Nolan Williams is an Associate Professor at Stanford. Nolan is founder of Magnus Medical and he’s leading an observational and neuroimaging study investigating the use of ibogaine in veterans
In this episode, we discuss…
The effects and mechanisms of different psychedelics (MDMA, psilocybin, ibogaine)
The role of therapy/support during psychedelic experiences
Scalability, accessibility, and optimal therapeutic use
Digital solutions, new care models, and policy changes
Listen to the episode here, on Spotify, or on Apple Podcasts.
Once you've finished the episode, we'd love to hear your thoughts! Tweet us at @psymedventures or email us at hi@psymed.ventures to share your views.
P.S. Do you know someone who would enjoy the Business Trip by PsyMed Ventures podcast? Feel free to share this newsletter by clicking the link below and hitting the ❤️ button on this post to help us reach more people on Substack 🙏